Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Intekhab Ahmed

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Pharmacology|January 17, 2014
The emerging role of oxylipins in thrombosis and diabetesBenjamin E Tourdot, Intekhab Ahmed, Michael Holinstat
Fertility and Sterility|November 17, 2019
Primary osteoporosis in men: an unmet medical needFabian A Mendoza, Michelle Le Roux, Intekhab Ahmed
Molecular Endocrinology (Baltimore, Md.)|May 10, 2003
Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblastsIntekhab Ahmed, Diane Gesty-Palmer, Marc K Drezner, et al.
American Journal of Therapeutics|February 17, 2007
Dual PPAR alpha/gamma agonists: promises and pitfalls in type 2 diabetesIntekhab Ahmed, Kevin Furlong, Jeremy Flood, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 10, 2013
Is above age 45 appropriate for upstaging well-differentiated papillary thyroid cancer?Lindsay A Bischoff, Joseph Curry, Intekhab Ahmed, et al.
Clinical Nuclear Medicine|August 10, 2011
Subclinical hyperthyroidism: current concepts and scintigraphic imagingCharles Intenzo, Serge Jabbour, Jeffrey L Miller, et al.
JBMR Plus|May 14, 2024
Open-label extension of a randomized trial investigating safety and efficacy of rhPTH(1-84) in hypoparathyroidismAliya A Khan, Lisa G Abbott, Intekhab Ahmed, et al.
Saudi Journal of Medicine & Medical Sciences|March 14, 2022
External Validation of 4C ISARIC Mortality Score in Critically ill COVID-19 Patients from Saudi ArabiaWaleed Tharwat Aletreby, Shahzad Ahmad Mumtaz, Saima Akhtar Shahzad, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 4, 2026
Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward TrialMishaela R Rubin, Bart L Clarke, Lorenz C Hofbauer, et al.
The Journal of Clinical Endocrinology and Metabolism|August 4, 2021
PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult HypoparathyroidismAliya A Khan, Lars Rejnmark, Mishaela Rubin, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Pharmacology|January 17, 2014
The emerging role of oxylipins in thrombosis and diabetesBenjamin E Tourdot, Intekhab Ahmed, Michael Holinstat
Fertility and Sterility|November 17, 2019
Primary osteoporosis in men: an unmet medical needFabian A Mendoza, Michelle Le Roux, Intekhab Ahmed
Molecular Endocrinology (Baltimore, Md.)|May 10, 2003
Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblastsIntekhab Ahmed, Diane Gesty-Palmer, Marc K Drezner, et al.
American Journal of Therapeutics|February 17, 2007
Dual PPAR alpha/gamma agonists: promises and pitfalls in type 2 diabetesIntekhab Ahmed, Kevin Furlong, Jeremy Flood, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 10, 2013
Is above age 45 appropriate for upstaging well-differentiated papillary thyroid cancer?Lindsay A Bischoff, Joseph Curry, Intekhab Ahmed, et al.
Clinical Nuclear Medicine|August 10, 2011
Subclinical hyperthyroidism: current concepts and scintigraphic imagingCharles Intenzo, Serge Jabbour, Jeffrey L Miller, et al.
JBMR Plus|May 14, 2024
Open-label extension of a randomized trial investigating safety and efficacy of rhPTH(1-84) in hypoparathyroidismAliya A Khan, Lisa G Abbott, Intekhab Ahmed, et al.
Saudi Journal of Medicine & Medical Sciences|March 14, 2022
External Validation of 4C ISARIC Mortality Score in Critically ill COVID-19 Patients from Saudi ArabiaWaleed Tharwat Aletreby, Shahzad Ahmad Mumtaz, Saima Akhtar Shahzad, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 4, 2026
Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward TrialMishaela R Rubin, Bart L Clarke, Lorenz C Hofbauer, et al.
The Journal of Clinical Endocrinology and Metabolism|August 4, 2021
PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult HypoparathyroidismAliya A Khan, Lars Rejnmark, Mishaela Rubin, et al.
Pageof 2